ProKidney Corp. Files 8-K on Agreement Changes
Ticker: PROK · Form: 8-K · Filed: Jul 14, 2025 · CIK: 1850270
| Field | Detail |
|---|---|
| Company | Prokidney Corp. (PROK) |
| Form Type | 8-K |
| Filed Date | Jul 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing-update
TL;DR
ProKidney Corp. just filed an 8-K about material agreements being entered and terminated. Watch for details.
AI Summary
On July 14, 2025, ProKidney Corp. filed an 8-K report detailing the entry into and termination of material definitive agreements. The company, formerly known as Social Capital Suvretta Holdings Corp. III, is incorporated in Delaware and operates in the biological products sector.
Why It Matters
This filing indicates significant shifts in ProKidney Corp.'s contractual relationships, which could impact its operational strategy and financial commitments.
Risk Assessment
Risk Level: medium — The termination of material definitive agreements can signal underlying business challenges or strategic realignments that warrant investor attention.
Key Numbers
- 001-40560 — SEC File Number (Identifies the company's filing with the SEC.)
- 98-1586514 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- PROKIDNEY CORP. (company) — Registrant
- Social Capital Suvretta Holdings Corp. III (company) — Former Company Name
- July 14, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 2000 Frontis Plaza Blvd., Suite 250, Winston-Salem, North Carolina 27103 (address) — Principal Executive Offices
FAQ
What were the specific material definitive agreements entered into by ProKidney Corp. on or before July 14, 2025?
The filing states that ProKidney Corp. entered into a material definitive agreement, but the specific details of this agreement are not provided in the excerpt.
What were the specific material definitive agreements terminated by ProKidney Corp. on or before July 14, 2025?
The filing indicates the termination of a material definitive agreement, but the specific details of this termination are not included in the provided text.
What is the primary business of ProKidney Corp.?
ProKidney Corp. operates in the sector of Biological Products (No Diagnostic Substances), as indicated by its Standard Industrial Classification code [2836].
When did ProKidney Corp. change its name from Social Capital Suvretta Holdings Corp. III?
The date of the name change from Social Capital Suvretta Holdings Corp. III to ProKidney Corp. was March 10, 2021.
Where are ProKidney Corp.'s principal executive offices located?
ProKidney Corp.'s principal executive offices are located at 2000 Frontis Plaza Blvd., Suite 250, Winston-Salem, North Carolina 27103.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 14, 2025 regarding PROKIDNEY CORP. (PROK).